Neuro Event Labs Oy closes EUR 3.9m Series A investment round from Hadean Ventures, SHS Gesellschaft für Beteiligungsmanagement and Maki.vc
December 18, 2019
Pipeline Therapeutics Completes $30 Million Series B Financing
September 18, 2019
Hadean Ventures invests in Themis Bioscience GmbH EUR 40m Series D Financing round
June 11, 2019
Hadean Ventures leads 40 million SEK (€3.7 million) investment round into SAGA to advance ultrasensitive cancer liquid biopsies
July 13, 2018
Hadean Ventures, SINTEF Venture V and Investinor invest in Nisonic AS to develop advanced ultrasound technology for neurological conditions.
May 22, 2018
Hadean Ventures today announces an investment in AttgeNO AB, a Swedish pharmaceutical company developing treatments for acute life-threatening conditions.
